Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7255 results

Sort By:

The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer

Study ID: NCT04927416
Start Date: 2021-10-25
End Date: 2030-11-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

54

Intervention / Treatment

68-Gall-dotatate-pet / ct

Sponsor

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Source: clinicaltrials.gov

Share:
Add to list

Human Laboratory Study of the Effects of Nicotine Product Claims on Appeal, Perceptions, and Use Behavior

Study ID: NCT06192316
Start Date: 2024-03-01
End Date: 2028-09-14
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

450

Intervention / Treatment

3x3 between-subjects experimental exposure

Sponsor

Ohio State University Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Evaluating Novel Therapies in ctDNA Positive GI Cancers

Study ID: NCT05482516
Start Date: 2023-03-29
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase3

No. of Participants

20

Intervention / Treatment

Atezolizumab

Infinite

Sponsor

Georgetown University

Source: clinicaltrials.gov

Share:
Add to list

Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)

Study ID: NCT04568616
Start Date: 2021-08-13
End Date: 2029-08-13
Study Type

Interventional

Study Phase

Phase2

No. of Participants

137

Intervention / Treatment

Letrozole 2.5mg

Sponsor

Dartmouth-Hitchcock Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Acalabrutinib in Combination With Venetoclax for the Treatment of Refractory or Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma, The AVENUE-2 Trial

Study ID: NCT04941716
Start Date: 2023-05-31
End Date: 2031-08-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Acalabrutib

Venetoclax

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Computed Tomography

Magnetic Resonance Imaging

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults With Cancer

Study ID: NCT05958316
Start Date: 2024-01-04
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

126

Intervention / Treatment

Computerized Symptom Capture Tool (C-SCAT) Intervention

Usual Care Control

Sponsor

Virginia Commonwealth University

Source: clinicaltrials.gov

Share:
Add to list

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

Study ID: NCT06859424
Start Date: 2025-07
End Date: 2028-06
Study Type

Interventional

Study Phase

Phase2

No. of Participants

358

Intervention / Treatment

Conditioning Regimen A

Conditioning Regimen B

Conditioning Regimen C

Conditioning Regimen D

Conditioning Regimen E

Hematopoietic Cell Transplantation

PTCy (50 mg/kg D3, D4)

PTCy (25 mg/kg D3, D4)

Post-transplant Tacrolimus

Post-transplant Mycophenolate mofetil

Post-transplant Abatacept

Post-transplant Ruxolitinib

Supportive Care: Growth Factors

Supportive Care: Blood Products

Supportive Care: Infection Prophylaxis

Supportive Care: Intravenous immune globulin (IVIG)

Supportive Care: Seizure prophylaxis

Supportive Care: Monitoring and management of CRS

Supportive Care: Prophylaxis against infections

Supportive Care: Prophylaxis against infections

Supportive Care: Lipid elevations

Study treatment compliance

Prohibited Concomitant Therapy

Permitted Concomitant Therapy

Prohibited Concomitant Therapy

Permitted Concomitant Therapy

Prohibited Concomitant Therapy

Permitted Concomitant Therapy

Sponsor

Center for International Blood and Marrow Transplant Research

Source: clinicaltrials.gov

Share:
Add to list

Raman Spectroscopy and Skin Cancer

Study ID: NCT06384924
Start Date: 2025-02-13
End Date: 2027-02-13
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

20

Intervention / Treatment

Raman Spectroscopy handheld probe (EmVision, FL, USA)

Raman Spectroscopy laser source (Hubner Photonics Inc, CA, USA)

Sponsor

Renee Farrell

Source: clinicaltrials.gov

Share:
Add to list

Personalized, Adaptive Treatment for Locally Advanced Head and Neck Cancer

Study ID: NCT06005324
Start Date: 2023-12-18
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

Paclitaxel

Carboplatin

Cetuximab

Standard Dose Radiation

Low Dose Radiation

Cisplatin

TFHX Regimen

Sponsor

University of Chicago

Source: clinicaltrials.gov

Share:
Add to list

A Study of Sovilnesib in Subjects with Ovarian Cancer

Study ID: NCT06084416
Start Date: 2024-04-04
End Date: 2025-07
Study Type

Interventional

Study Phase

Phase1

No. of Participants

120

Intervention / Treatment

Chuckle

Sponsor

Volastra Therapeutics, Inc.

Source: clinicaltrials.gov

Share:
Add to list